Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

  • Author: Kristine Patterson, MD (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 5/3/19 (What's New)

Summary

  • ART should be initiated in all HIV-infected pregnant women regardless of CD4+ cell count or HIV-1 RNA level
  • Resistance testing, CBC, and renal and liver function testing should be obtained before treatment initiation
  • Appropriate OI prophylaxis should be started based on CD4+ cell count

Action required

Keywords: Initial Antiretroviral Therapy, Pregnancy, Women

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.